Results 21 to 30 of about 92,480 (295)

PI3K-AKT Signaling via Nrf2 Protects against Hyperoxia-Induced Acute Lung Injury, but Promotes Inflammation Post-Injury Independent of Nrf2 in Mice.

open access: yesPLoS ONE, 2015
Lung epithelial and endothelial cell death accompanied by inflammation contributes to hyperoxia-induced acute lung injury (ALI). Impaired resolution of ALI can promote and/or perpetuate lung pathogenesis, including fibrosis.
Narsa M Reddy   +5 more
doaj   +2 more sources

Anti-Osteoarthritis Mechanism of the Nrf2 Signaling Pathway

open access: yesBiomedicines, 2023
Osteoarthritis (OA) is a chronic degenerative disease and the primary pathogenic consequence of OA is inflammation, which can affect a variety of tissues including the synovial membrane, articular cartilage, and subchondral bone.
Sarmistha Saha, Nazih Y. Rebouh
doaj   +4 more sources

Keap1/Nrf2 Signaling in Aged Bone

open access: yes
IUPUIBone health is a critical element in mammalian quality of life. The Keap1/Nrf2 signaling pathway has recently been observed to be instrumental in a multitude of regulatory processes pertaining to cytoprotective gene expression, with growing evidence
Sandy, Brandon
core   +2 more sources

NRF2 signaling in cytoprotection and metabolism

open access: yesBritish Journal of Pharmacology, 2023
The KEAP1-NRF2 system plays a central role in cytoprotection and defense mechanisms against oxidative stress. Because KEAP1 serves as a biosensor for electrophiles by using its reactive thiols and because NRF2 is a transcriptional factor regulating genes involved in the sulfur-mediated redox reactions, the KEAP1-NRF2 system has been regarded as a ...
Shohei Murakami   +4 more
openaire   +2 more sources

Keap1/Nrf2 Signaling Pathway [PDF]

open access: yesAntioxidants, 2021
Nuclear factor, erythroid 2-like transcription factor 2 (Nrf2) and its cytoplasmic inhibitor, kelch-like ECH-associated protein 1 (Keap1), comprise a redox-responsive endogenous antioxidant defense module that orchestrates the expression of cytoprotective genes to maintain homeostasis [...]
openaire   +4 more sources

Nrf2 Signaling in Macrophages [PDF]

open access: yesReactive Oxygen Species, 2016
The nuclear factor E2-related factor 2 (Nrf2) is known as the chief regulator of cellular antioxidant defenses as well as a suppressor of inflammation. Macrophages act as major players in inflammatory responses. Because oxidative stress and inflammation are two intertwined processes, the anti-inflammatory activity of Nrf2 signaling is believed to ...
Hong, Zhu, Zhenquan, Jia, Y Robert, Li
openaire   +2 more sources

Nrf2 signaling and cell survival [PDF]

open access: yesToxicology and Applied Pharmacology, 2010
Nrf2:INrf2 acts as a sensor for oxidative/electrophilic stress. INrf2 serves as an adaptor to link Nrf2 to the ubiquitin ligase Cul3-Rbx1 complex that ubiquitinate and degrade Nrf2. Under basal conditions, cytosolic INrf2/Cul3-Rbx1 is constantly degrading Nrf2.
Suryakant K, Niture   +3 more
openaire   +2 more sources

Keap1–Nrf2 signalling in pancreatic cancer [PDF]

open access: yesThe International Journal of Biochemistry & Cell Biology, 2015
Transcription factor NF-E2 p45-related factor 2 (Nrf2, also called Nfe2l2), a master regulator of redox homeostasis, and its dominant negative regulator, Kelch-like ECH-associated protein 1 (Keap1), together tightly control the expression of numerous detoxifying and antioxidant genes.
Hayes, Alastair J   +3 more
openaire   +2 more sources

The Role of Toxic Metals and Metalloids in Nrf2 Signaling [PDF]

open access: yesAntioxidants, 2021
Nuclear factor erythroid 2-related factor 2 (Nrf2), an emerging regulator of cellular resistance to oxidants, serves as one of the key defensive factors against a range of pathological processes such as oxidative damage, carcinogenesis, as well as various harmful chemicals, including metals.
Aleksandra Buha   +6 more
openaire   +6 more sources

Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer [PDF]

open access: yesMolecules, 2021
Cancer is one of the most fatal diseases with an increasing incidence and mortality all over the world. Thus, there is an urgent need for novel therapies targeting major cancer-related pathways. Nuclear factor-erythroid 2-related factor 2 (NRF2) and its major negative modulator Kelch-like ECH-associated protein 1 (KEAP1) are main players of the ...
Pelin Telkoparan-Akillilar   +4 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy